vs
Side-by-side financial comparison of American Healthcare REIT, Inc. (AHR) and PERRIGO Co plc (PRGO). Click either name above to swap in a different company.
PERRIGO Co plc is the larger business by last-quarter revenue ($1.1B vs $564.0M, roughly 2.0× American Healthcare REIT, Inc.). American Healthcare REIT, Inc. runs the higher net margin — 1.9% vs -127.8%, a 129.7% gap on every dollar of revenue. On growth, American Healthcare REIT, Inc. posted the faster year-over-year revenue change (13.5% vs -2.5%). Over the past eight quarters, American Healthcare REIT, Inc.'s revenue compounded faster (11.7% CAGR vs 1.3%).
Medical Properties Trust, Inc. (MPT) is an international real estate investment trust (REIT) based in Birmingham, Alabama that purchases and invests in healthcare facilities and for-profit healthcare holding companies, primarily in the United States and Europe. Their property acquisitions often come in the form of sale-leaseback agreements, in which the original property owner sells the property to MPT and becomes their tenant. MPT's tenants are generally subject to long-term triple net lease...
Perrigo Company plc is an American Irish-registered manufacturer of private label over-the-counter pharmaceuticals, and while 70% of Perrigo's net sales are from the U.S. healthcare system, Perrigo is legally headquartered in Ireland for tax purposes, which accounts for 0.60% of net sales. In 2013, Perrigo completed the sixth-largest US corporate tax inversion in history when it reregistered its tax status to Ireland to avoid U.S. corporate taxes. Perrigo maintains its corporate headquarters ...
AHR vs PRGO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $564.0M | $1.1B |
| Net Profit | $10.8M | $-1.4B |
| Gross Margin | 14.8% | 32.6% |
| Operating Margin | 19.8% | -116.0% |
| Net Margin | 1.9% | -127.8% |
| Revenue YoY | 13.5% | -2.5% |
| Net Profit YoY | 133.9% | -3093.9% |
| EPS (diluted) | $0.07 | $-10.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $564.0M | $1.1B | ||
| Q3 25 | $532.1M | $1.0B | ||
| Q2 25 | $501.3M | $1.1B | ||
| Q1 25 | $497.2M | $1.0B | ||
| Q4 24 | $496.8M | $1.1B | ||
| Q3 24 | $476.8M | $1.1B | ||
| Q2 24 | $458.0M | $1.1B | ||
| Q1 24 | $452.1M | $1.1B |
| Q4 25 | $10.8M | $-1.4B | ||
| Q3 25 | $55.9M | $7.5M | ||
| Q2 25 | $9.9M | $-8.4M | ||
| Q1 25 | $-6.8M | $-6.4M | ||
| Q4 24 | $-31.8M | $-44.4M | ||
| Q3 24 | $-4.1M | $-21.0M | ||
| Q2 24 | $2.0M | $-108.4M | ||
| Q1 24 | $-3.9M | $2.0M |
| Q4 25 | 14.8% | 32.6% | ||
| Q3 25 | 14.6% | 36.1% | ||
| Q2 25 | 15.0% | 34.4% | ||
| Q1 25 | 13.0% | 37.6% | ||
| Q4 24 | 13.3% | 33.9% | ||
| Q3 24 | 12.5% | 37.2% | ||
| Q2 24 | 12.1% | 37.0% | ||
| Q1 24 | 10.7% | 33.1% |
| Q4 25 | 19.8% | -116.0% | ||
| Q3 25 | 19.9% | 7.0% | ||
| Q2 25 | 20.6% | 4.3% | ||
| Q1 25 | 19.0% | 4.5% | ||
| Q4 24 | 20.0% | 10.0% | ||
| Q3 24 | 19.6% | 7.4% | ||
| Q2 24 | 19.4% | -2.5% | ||
| Q1 24 | 18.2% | -5.1% |
| Q4 25 | 1.9% | -127.8% | ||
| Q3 25 | 10.5% | 0.7% | ||
| Q2 25 | 2.0% | -0.8% | ||
| Q1 25 | -1.4% | -0.6% | ||
| Q4 24 | -6.4% | -3.9% | ||
| Q3 24 | -0.9% | -1.9% | ||
| Q2 24 | 0.4% | -10.2% | ||
| Q1 24 | -0.9% | 0.2% |
| Q4 25 | $0.07 | $-10.23 | ||
| Q3 25 | $0.33 | $0.05 | ||
| Q2 25 | $0.06 | $-0.06 | ||
| Q1 25 | $-0.04 | $-0.05 | ||
| Q4 24 | $-0.23 | $-0.32 | ||
| Q3 24 | $-0.03 | $-0.15 | ||
| Q2 24 | $0.01 | $-0.79 | ||
| Q1 24 | $-0.04 | $0.01 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $114.8M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $3.3B | $2.9B |
| Total Assets | $5.4B | $8.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.8M | — | ||
| Q3 25 | $147.4M | $432.1M | ||
| Q2 25 | $133.5M | $454.2M | ||
| Q1 25 | $86.1M | $409.9M | ||
| Q4 24 | $76.7M | $558.8M | ||
| Q3 24 | $67.8M | $1.5B | ||
| Q2 24 | $52.1M | $542.8M | ||
| Q1 24 | $77.0M | $658.5M |
| Q4 25 | $3.3B | $2.9B | ||
| Q3 25 | $2.7B | $4.4B | ||
| Q2 25 | $2.4B | $4.5B | ||
| Q1 25 | $2.3B | $4.4B | ||
| Q4 24 | $2.3B | $4.3B | ||
| Q3 24 | $2.2B | $4.6B | ||
| Q2 24 | $1.9B | $4.5B | ||
| Q1 24 | $2.0B | $4.7B |
| Q4 25 | $5.4B | $8.5B | ||
| Q3 25 | $4.8B | $10.1B | ||
| Q2 25 | $4.5B | $10.1B | ||
| Q1 25 | $4.5B | $9.8B | ||
| Q4 24 | $4.5B | $9.6B | ||
| Q3 24 | $4.7B | $11.2B | ||
| Q2 24 | $4.6B | $10.4B | ||
| Q1 24 | $4.7B | $10.6B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $55.2M | $175.4M |
| Free Cash FlowOCF − Capex | — | $148.6M |
| FCF MarginFCF / Revenue | — | 13.4% |
| Capex IntensityCapex / Revenue | — | 2.4% |
| Cash ConversionOCF / Net Profit | 5.12× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $145.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $55.2M | $175.4M | ||
| Q3 25 | $107.2M | $51.7M | ||
| Q2 25 | $71.5M | $75.9M | ||
| Q1 25 | $60.6M | $-64.5M | ||
| Q4 24 | $59.5M | $312.6M | ||
| Q3 24 | $63.1M | $42.2M | ||
| Q2 24 | $59.4M | $9.5M | ||
| Q1 24 | $-6.0M | $-1.4M |
| Q4 25 | — | $148.6M | ||
| Q3 25 | — | $29.8M | ||
| Q2 25 | — | $56.7M | ||
| Q1 25 | — | $-90.0M | ||
| Q4 24 | — | $274.9M | ||
| Q3 24 | — | $15.1M | ||
| Q2 24 | — | $-18.9M | ||
| Q1 24 | — | $-26.5M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 5.4% | ||
| Q1 25 | — | -8.6% | ||
| Q4 24 | — | 24.2% | ||
| Q3 24 | — | 1.4% | ||
| Q2 24 | — | -1.8% | ||
| Q1 24 | — | -2.4% |
| Q4 25 | — | 2.4% | ||
| Q3 25 | — | 2.1% | ||
| Q2 25 | — | 1.8% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.3% | ||
| Q3 24 | — | 2.5% | ||
| Q2 24 | — | 2.7% | ||
| Q1 24 | — | 2.3% |
| Q4 25 | 5.12× | — | ||
| Q3 25 | 1.92× | 6.89× | ||
| Q2 25 | 7.21× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 30.02× | — | ||
| Q1 24 | — | -0.70× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
AHR
| Integrated Senior Health Campuses | $467.0M | 83% |
| SHOP | $97.0M | 17% |
PRGO
| Consumer Self Care Americas | $697.0M | 63% |
| Digestive Health | $123.9M | 11% |
| Nutrition | $108.3M | 10% |
| Healthy Lifestyle | $94.8M | 9% |
| Pain And Sleep Aids | $87.1M | 8% |
